L\u2019IDIBELL i la Unitat Funcional d\u2019Asma del Servei de Pneumologia de l\u2019Hospital de Bellvitge (HUB) han participat en un estudi que compara la resposta a diferents f\u00e0rmacs biol\u00f2gics (anticossos monoclonals) en pacients amb \u00fanicament asma i d\u2019altres que a m\u00e9s tenen diagnosticat MPOC, en el que es coneix com a s\u00edndrome de solapament ACO, (Asthma-COPD overlap). \u00a0En aquests casos, es produeix una obstrucci\u00f3 irreversible del flux aeri, amb s\u00edmptomes cl\u00ednics d\u2019asma\u00a0associats al dany pulmonar per la MPOC. L’asma \u00e9s la malaltia respirat\u00f2ria m\u00e9s prevalent, amb una base immunol\u00f2gica-inflamat\u00f2ria moltes vegades previsible i tractable. Nom\u00e9s un grup redu\u00eft de pacients amb asma, per\u00f2, com els esmentats d\u2019ACO presenten formes greus de la malaltia i necessiten tractaments immunoespec\u00edfics com els f\u00e0rmacs biol\u00f2gics.<\/p>\n
L\u2019estudi multic\u00e8ntric en vida real a nivell estatal, s\u2019ha realitzat amb pacients amb asma greu d\u2019una desena hospitals i la seva principal conclusi\u00f3 \u00e9s que la ter\u00e0pia biol\u00f2gica \u00e9s efectiva en tots dos casos, \u201ctot i que la resposta \u00e9s molt m\u00e9s efectiva en els pacients amb asma greu<\/em>\u201d, segon afirma la Dra. Mariana Mu\u00f1oz<\/strong>, coordinadora de la Unitat Funcional d\u2019Asma del Servei de Pneumologia de l\u2019HUB i investigadora de l\u2019IDIBELL. L\u2019efectivitat dels tractaments s\u2019ha avaluat en base al nombre d’aguditzacions i els ingressos hospitalaris, la presa de corticoides orals i els s\u00edmptomes diaris durant els primers 12 mesos de tractament.<\/p>\n Com a dada addicional, la Dra. Mu\u00f1oz<\/strong> destaca la import\u00e0ncia de recordar que \u201cla mesura m\u00e9s efectiva en l’abordatge de <\/em>la MPOC \u00e9s la prevenci\u00f3 prim\u00e0ria, \u00e9s a dir, l’abandonament o abstin\u00e8ncia del tabac i altres fums inhalats, sobretot en aquells pacients amb malalties respirat\u00f2ries pr\u00e8vies com l’asma<\/em>\u201d.<\/p>\n <\/p>\n <\/p>\n L\u2019Institut d’Investigaci\u00f3 Biom\u00e8dica de Bellvitge (IDIBELL) \u00e9s un centre de recerca en biomedicina creat l\u2019any 2004. Est\u00e0 participat per l’Hospital Universitari de Bellvitge i l\u2019Hospital de Viladecans de l’Institut Catal\u00e0 de la Salut, l’Institut Catal\u00e0 d’Oncologia, la Universitat de Barcelona i l\u2019Ajuntament de l\u2019Hospitalet de Llobregat.<\/em><\/p>\n L\u2019IDIBELL \u00e9s membre del Campus d’Excel\u00b7l\u00e8ncia Internacional de la Universitat de Barcelona HUBc i forma part de la instituci\u00f3 CERCA de la Generalitat de Catalunya. L’any 2009 es va convertir en un dels cinc primers centres d\u2019investigaci\u00f3 espanyols acreditats com a institut d\u2019investigaci\u00f3 sanit\u00e0ria per l\u2019Instituto de Salud Carlos III. A m\u00e9s, forma part del programa \u201cHR Excellence in Research\u201d de la Uni\u00f3 Europea i \u00e9s membre de EATRIS i REGIC. Des de l\u2019any 2018, l\u2019IDIBELL \u00e9s un Centro Acreditado de la Fundaci\u00f3n Cient\u00edfica AECC (FCAECC).<\/em><\/p>\n","protected":false},"excerpt":{"rendered":" L\u2019estudi multic\u00e8ntric en vida real a nivell estatal, s\u2019ha realitzat amb pacients amb asma greu d\u2019una desena hospitals i la seva principal conclusi\u00f3 \u00e9s que la ter\u00e0pia biol\u00f2gica \u00e9s efectiva en tots dos casos<\/p>\n","protected":false},"author":8,"featured_media":22131,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-22130","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"publishpress_future_action":{"enabled":false,"date":"2024-12-30 05:42:51","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=22130"}],"version-history":[{"count":1,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22130\/revisions"}],"predecessor-version":[{"id":22132,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/22130\/revisions\/22132"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/22131"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=22130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=22130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=22130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}